Form 4: 89bio, Inc. Executive Sarena Francis Willard Reports Stock and Option Transactions

Chief Operating Officer Sarena Francis Willard reports acquisition and disposal of 89bio, Inc. stock and acquisition of stock options.

Summary

• On February 1, 2025, Sarena Francis Willard, Chief Operating Officer of 89bio, Inc., reported transactions involving the company's stock.
• Willard acquired 53,750 shares of common stock at $0 and disposed of 78,750 shares.
• Following these transactions, Willard directly owns 78,750 shares of 89bio, Inc.
• Willard also acquired options to purchase 215,000 shares of common stock at an exercise price of $9.60, which expire on February 1, 2035.
• These options vest over a period of four years, with one quarter vesting on February 1, 2026, and the remainder vesting quarterly thereafter, contingent upon continued service to the Issuer.

Sentiment

Score: 5

Explanation: This is a neutral report of stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Future Outlook

The vesting of the restricted stock units and stock options is contingent upon the Reporting Person's continued service to the Issuer.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, as required by the SEC. It provides transparency to investors regarding insider activity.

Stakeholder Impact

• The transactions may be of interest to shareholders as they provide insight into the actions of a key executive.

Key Dates

Keywords

Form 4, Beneficial Ownership, Stock Options, Stock Transactions, Sarena Francis Willard, 89bio, Inc., ETNB, COO